Lefebvre Eric — SEC Form 4 filings
SEC reporting owner CIK 1614741. 8 Form 4 filings on record with FilingPulse; latest filed 2025-01-27.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-19 to 2025-01-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 41,092 shares, $526,764 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 18,478 shares @ $11.20 ($206,974) in PLIANT THERAPEUTICS, INC., filed 2025-01-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | Chief Medical Officer | 6 | — | 3 legs · 41,092 sh · $526,764 | 5 |
| CymaBay Therapeutics, Inc. (CBAY) | Director | 2 | — | — | 4 |
Form 4 filings — Lefebvre Eric
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-27 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 45,650 @ $0 · Grant/award (A): 91,300 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Sale (S): 18,478 @ $11.20 | EDGAR |
| 2024-07-12 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Sale (S): 12,319 @ $11.56 | EDGAR |
| 2024-07-11 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 24,063 @ $0 | EDGAR |
| 2024-03-22 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to issuer (D): 115,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 14,010 (derivative) | EDGAR |
| 2024-01-26 | 4 | CymaBay Therapeutics, Inc. (CBAY) | Grant/award (A): 14,010 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 42,900 @ $0 · Grant/award (A): 85,800 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Sale (S): 10,295 @ $17.23 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1614741 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →